Literature DB >> 1315341

Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women.

M Evander1, K Edlund, E Bodén, A Gustafsson, M Jonsson, R Karlsson, E Rylander, G Wadell.   

Abstract

The prevalence of human papillomavirus (HPV) infection in cervical cell scrapes from young women was determined by polymerase chain reaction (PCR) by using general primer pairs localized within the L1 region. With a one-step general PCR, 5.9% (35 of 590) of young women in a population-based study were found to contain HPV DNA. The proportion of HPV-positive women increased with age, from 1.4% (1 of 69) among women aged 19 years to 9.2% (13 of 142) among women aged 25 years. Among the cervical scrapes from women with normal cytology, 5.6% (30 of 539) harbored HPV DNA. A total of 5 of 19 (26.3%) of the women with pathological signs were positive for HPV DNA. By a two-step PCR, using nested general primers, 20.3% (118 of 581) of all women were shown to contain HPV DNA. The proportion of HPV-positive women also increased with age, from 17.4% (12 of 69) among women aged 19 years to 31.9% (43 of 135) among women aged 25 years, when the two-step PCR was used. Some 19.2% (102 of 530) of cervical scrapes from women with normal cytology contained HPV DNA. Among the women with pathological signs, 16 of 19 (84.2%) were positive for HPV DNA. The HPV DNA-positive specimens were demonstrated to contain HPV type 6, 11, 16, 18, 31, 33, 35, 39, 40, 45, 55, or 56. The most prevalent HPV types were 6 (2.0%) and 16 (2.7%). More than one type was found in 16 specimens. Sixty HPV-positive samples could not be typed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315341      PMCID: PMC265198          DOI: 10.1128/jcm.30.4.987-992.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA.

Authors:  M H Schiffman; H M Bauer; A T Lorincz; M M Manos; J C Byrne; A G Glass; D M Cadell; P M Howley
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

Review 2.  Heterogeneity of the human papillomavirus group.

Authors:  E M de Villiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

3.  Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population-based cross-sectional study.

Authors:  S K Kjaer; E M de Villiers; B J Haugaard; R B Christensen; C Teisen; K A Møller; P Poll; H Jensen; B F Vestergaard; E Lynge
Journal:  Int J Cancer       Date:  1988-04-15       Impact factor: 7.396

4.  Biology and biochemistry of papillomaviruses.

Authors:  H Pfister
Journal:  Rev Physiol Biochem Pharmacol       Date:  1984       Impact factor: 5.545

5.  Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata.

Authors:  L T Chow; M Nasseri; S M Wolinsky; T R Broker
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

6.  Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction.

Authors:  A J van den Brule; C J Meijer; V Bakels; P Kenemans; J M Walboomers
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

7.  General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas.

Authors:  A J van den Brule; P J Snijders; R L Gordijn; O P Bleker; C J Meijer; J M Walboomers
Journal:  Int J Cancer       Date:  1990-04-15       Impact factor: 7.396

8.  Oligonucleotide primers for DNA amplification of the early regions 1, 6, and 7 from human papillomavirus types 6, 11, 16, 18, 31, and 33.

Authors:  M Evander; E Bodén; L Bjersing; E Rylander; G Wadell
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Human papillomavirus infections in women with and without abnormal cervical cytology.

Authors:  E M de Villiers; D Wagner; A Schneider; H Wesch; H Miklaw; J Wahrendorf; U Papendick; H zur Hausen
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

10.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Authors:  M Dürst; L Gissmann; H Ikenberg; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  31 in total

1.  A novel and rapid PCR-based method for genotyping human papillomaviruses in clinical samples.

Authors:  J H Nelson; G A Hawkins; K Edlund; M Evander; L Kjellberg; G Wadell; J Dillner; T Gerasimova; A L Coker; L Pirisi; D Petereit; P F Lambert
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk.

Authors:  Gisela Barbisan; Luis Orlando Pérez; Anahí Contreras; Carlos Daniel Golijow
Journal:  Tumour Biol       Date:  2012-05-17

3.  Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers.

Authors:  C M Black; P I Fields; T O Messmer; B P Berdal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

4.  Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms.

Authors:  F Blasi; F Denti; M Erba; R Cosentini; R Raccanelli; A Rinaldi; L Fagetti; G Esposito; U Ruberti; L Allegra
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

5.  Human papillomavirus (HPV) DNA is not detected in the peripheral blood cells of patients with cervical carcinoma.

Authors:  I Lewensohn-Fuchs; Z Berke; D Wester; T Dalianis; K Elfgren
Journal:  Genitourin Med       Date:  1994-10

6.  Human papillomavirus DNA and oncogene alterations in colorectal tumors.

Authors:  Luis Orlando Pérez; Gisela Barbisan; Anabel Ottino; Horacio Pianzola; Carlos Daniel Golijow
Journal:  Pathol Oncol Res       Date:  2010-03-17       Impact factor: 3.201

7.  XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk.

Authors:  Luis Orlando Pérez; Andrea Crivaro; Gisela Barbisan; Lucia Poleri; Carlos Daniel Golijow
Journal:  Pathol Oncol Res       Date:  2013-03-29       Impact factor: 3.201

8.  Detection and typing of human papillomavirus by e6 nested multiplex PCR.

Authors:  K Sotlar; D Diemer; A Dethleffs; Y Hack; A Stubner; N Vollmer; S Menton; M Menton; K Dietz; D Wallwiener; R Kandolf; B Bültmann
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic.

Authors:  Petroula Stamataki; Athanasia Papazafiropoulou; Ioannis Elefsiniotis; Margarita Giannakopoulou; Hero Brokalaki; Eleni Apostolopoulou; Pavlos Sarafis; George Saroglou
Journal:  BMC Infect Dis       Date:  2010-02-15       Impact factor: 3.090

10.  Sensitive HPV detection in oropharyngeal cancers.

Authors:  David M Winder; Siolian L R Ball; Katie Vaughan; Nashat Hanna; Yin Ling Woo; Jürgen-Theodor Fränzer; Jane C Sterling; Margaret A Stanley; Holger Sudhoff; Peter K C Goon
Journal:  BMC Cancer       Date:  2009-12-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.